Pfizer Agrees to Support CDC Opioid Guideline
https://www.painnewsnetwork.org/stories/2017/8/4/pfizer-agrees-to-support-cdc-opioid-guideline
By Pat Anson, Editor
Since its release in March 2016, the CDC’s opioid prescribing guideline has had a chilling effect on chronic pain patients, as doctors, regulators, states and insurance companies have adopted the CDC’s recommendations as policies or even laws. As a result, it has become harder for many pain patients to get opioids prescribed or even find a doctor willing to treat them.
Now one of the world’s largest drug makers has agreed not to make any statements that conflict with the CDC guideline and to withdraw support for anyone who does.
In an agreement signed last month with the Santa Clara County, California Counsel’s Office, Pfizer promised to abide by strict standards in its marketing of opioids and to “not make or disseminate claims that are contrary to the ‘Recommendations’ of the Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain.”
That voluntary guideline only discourages primary care physicians from prescribing opioids for chronic pain, but has been widely implemented by many doctors, regardless of specialty.
Pfizer also agreed to stop funding patient advocacy groups, healthcare organizations or any charities that make “misleading statements” about opioids that are contrary to the CDC guidelines. Pfizer notified Pain News Network by email today that it was rescinding a charitable grant recently awarded to PNN. Pfizer’s had been a sponsor of PNN’s newsletter for the past year.
“This agreement is an important step in ensuring that doctors and patients in California receive accurate information about the risks and benefits of these highly addictive painkillers,” Santa Clara County Counsel James Williams said in a press release. “Such information is essential to curbing — and ultimately ending — the opioid epidemic plaguing Santa Clara County, the State of California, and many parts of the country.”
Santa Clara County was not pursuing any legal action against Pfizer, although it had filed a lawsuit against Purdue Pharma and four other opioid manufacturers, alleging that they falsely downplayed the risks of opioid painkillers and grossly exaggerated their benefits.
“We applaud Pfizer’s willingness to work with us to combat the dramatic rise in opioid misuse, abuse, and addiction in California and the corresponding rise in overdose deaths, hospitalizations, and crime,” said Danny Chou, an Assistant County Counsel for the County of Santa Clara. “Pfizer has set a stringent standard that we expect all other opioid manufacturers to meet.”
Opioids make up only a tiny part of Pfizer’s business. The company sells just one opioid painkiller, an extended release medication called Emedea.
As part of its agreement with Santa Clara County, Pfizer promised not to market opioids off-label for conditions they are not approved for and said it would “make clear” in its marketing that there are no long-term studies on the safe use of opioids.
Interestingly, the CDC guideline suggests the use of gabapentin and pregabalin as alternatives to opioids for treating pain. Pfizer makes billions of dollars annually selling both of those drugs, under the brand names Neurontin and Lyrica.
In recent years, Pfizer has paid $945 million in fines to resolve criminal and civil charges that it marketed Neurontin off-label to treat conditions it was not approved for. Neurontin is only approved by the FDA to treat epilepsy and neuropathic pain caused by shingles, but it is widely prescribed off label to treat depression, ADHD, migraine, fibromyalgia and bipolar disorder. According to one estimate, over 90% of Neurontin sales are for off-label uses.
Lyrica is approved by the FDA to treat diabetic nerve pain, fibromyalgia, post-herpetic neuralgia caused by shingles and spinal cord injuries. Lyrica is also prescribed off-label to treat a wide variety of other chronic pain conditions, including lumbar spinal stenosis, the most common type of lower back pain in older adults.
Since I don’t receive any money from Pfizer – except for some dividends from some Pfizer stock that I have owned for nearly 10 yrs.. I can say whatever I think about this announcement..
First of all … Santa Clara County, California has a population of about 1.9 million or about 0.5% of the population of the USA… which means that this county prosecutor in CALF has been able to impose his will, belief, opinions on the other 99.5% of the country’s population…
WHAT A EGO.. and clearly demonstrates that our judicial system has gotten totally out of control. Just like recently AG Session wanted to be granted the power to allow him to impose his opinions on the entire population … especially when it came to the war on drugs.
The CDC ( Center of Disease Control) produced these “guidelines” and some believe that the CDC did not have the legal authority to do so… Up until the release of these guidelines.. the CDC primary focus on communicable diseases and vaccines that help prevent communicable diseases and/or establish treatment plans to deal with communicable disease.
It has been stated that the studies/data that the CDC based it guidelines on were of the poor quality… with 1= excellent and 4 = unreliable and most of the studies they used had a rating of 3 or 4 and they refused to accept any anecdotal evidence of the benefit of opiates used long term in helping pts manage their chronic pain.
The head of the CDC at the time – Tom Frieden – was quick to make public statements pointing out once these guidelines were released that they were merely GUIDELINES and did not bear the weight of law.
However, many entities – like the VA – was quick to adopt some of the most strict portion of the CDC guidelines and ignored some of the exceptions in order to properly manage the pain of chronic pain pts with more severe pain.
It amazes me that both the FDA and Pfizer does not recommend the use of one of Pfizer’s medications in ESI and all too many pts have been inflicted with Arachnoiditis https://en.wikipedia.org/wiki/Arachnoiditis and meningitis and no one seems to be interested in this very popular procedure that may be considered insurance fraud and causing insurance companies expending untold dollars treating Arachnoiditis… which is both incurable, extremely painful and costly to treat.
It would seem that our judicial system is more interested in the loss of life from people abusing illegal substances than those pt losing their quality of life from physicians “pushing” procedures using medications in an unproved methodologies.
Filed under: General Problems | 5 Comments »